Gestational diabetes

Leanne K. Piper; Zoe Stewart; Helen R. Murphy

doi:10.1016/j.ogrm.2017.03.004

Gestational diabetes

Leanne K. Piper, Zoe Stewart, Helen R. Murphy

Research output: Contribution to journal › Article › peer-review

8 Citations (SciVal)

18 Downloads (Pure)

Abstract

Gestational diabetes mellitus (GDM) is defined as hyperglycaemia that is diagnosed for the first time in the second or third trimester of pregnancy. It occurs in 1 in 7 pregnancies worldwide and is associated with increased risk of adverse perinatal outcome, in particular, infant birth weight that is large for gestational age, increased infant adiposity, preeclampsia and preterm delivery, and increased delivery by caesarean section. This review focuses on the controversy regarding screening and diagnosis of GDM following development of the International Association of Diabetes and Pregnancy Study Groups (IADPSG) guidelines and the National Institute of Clinical Excellence (NICE) 2015 guidelines. It reviews the most recent research in to diet and exercise modification in prevention and management of GDM, pharmacological management and post-partum management to delay and/or prevent progression to type 2 diabetes.

Original language	English
Pages (from-to)	171–176
Number of pages	6
Journal	Obstetrics, Gynaecology & Reproductive Medicine
Volume	27
Issue number	6
Early online date	26 Apr 2017
DOIs	https://doi.org/10.1016/j.ogrm.2017.03.004
Publication status	Published - Jun 2017

Keywords

Diabetes
Gestational Diabetes
hyperglycaemia in pregnancy
pregnancy complications
screening
large for gestational age
blood glucose
Pregnancy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ogrm.2017.03.004

Accepted manuscriptAccepted author manuscript, 288 KBLicence: CC BY-NC-ND

Cite this

@article{406ee35fd0b9488b89789b6fbaa626d6,

title = "Gestational diabetes",

abstract = "Gestational diabetes mellitus (GDM) is defined as hyperglycaemia that is diagnosed for the first time in the second or third trimester of pregnancy. It occurs in 1 in 7 pregnancies worldwide and is associated with increased risk of adverse perinatal outcome, in particular, infant birth weight that is large for gestational age, increased infant adiposity, preeclampsia and preterm delivery, and increased delivery by caesarean section. This review focuses on the controversy regarding screening and diagnosis of GDM following development of the International Association of Diabetes and Pregnancy Study Groups (IADPSG) guidelines and the National Institute of Clinical Excellence (NICE) 2015 guidelines. It reviews the most recent research in to diet and exercise modification in prevention and management of GDM, pharmacological management and post-partum management to delay and/or prevent progression to type 2 diabetes. ",

keywords = "Diabetes, Gestational Diabetes, hyperglycaemia in pregnancy, pregnancy complications, screening, large for gestational age, blood glucose, Pregnancy",

author = "Piper, {Leanne K.} and Zoe Stewart and Murphy, {Helen R.}",

year = "2017",

month = jun,

doi = "10.1016/j.ogrm.2017.03.004",

language = "English",

volume = "27",

pages = "171–176",

journal = "Obstetrics, Gynaecology & Reproductive Medicine",

issn = "1879-3622",

publisher = "Churchill Livingstone",

number = "6",

}

TY - JOUR

T1 - Gestational diabetes

AU - Piper, Leanne K.

AU - Stewart, Zoe

AU - Murphy, Helen R.

PY - 2017/6

Y1 - 2017/6

N2 - Gestational diabetes mellitus (GDM) is defined as hyperglycaemia that is diagnosed for the first time in the second or third trimester of pregnancy. It occurs in 1 in 7 pregnancies worldwide and is associated with increased risk of adverse perinatal outcome, in particular, infant birth weight that is large for gestational age, increased infant adiposity, preeclampsia and preterm delivery, and increased delivery by caesarean section. This review focuses on the controversy regarding screening and diagnosis of GDM following development of the International Association of Diabetes and Pregnancy Study Groups (IADPSG) guidelines and the National Institute of Clinical Excellence (NICE) 2015 guidelines. It reviews the most recent research in to diet and exercise modification in prevention and management of GDM, pharmacological management and post-partum management to delay and/or prevent progression to type 2 diabetes.

AB - Gestational diabetes mellitus (GDM) is defined as hyperglycaemia that is diagnosed for the first time in the second or third trimester of pregnancy. It occurs in 1 in 7 pregnancies worldwide and is associated with increased risk of adverse perinatal outcome, in particular, infant birth weight that is large for gestational age, increased infant adiposity, preeclampsia and preterm delivery, and increased delivery by caesarean section. This review focuses on the controversy regarding screening and diagnosis of GDM following development of the International Association of Diabetes and Pregnancy Study Groups (IADPSG) guidelines and the National Institute of Clinical Excellence (NICE) 2015 guidelines. It reviews the most recent research in to diet and exercise modification in prevention and management of GDM, pharmacological management and post-partum management to delay and/or prevent progression to type 2 diabetes.

KW - Diabetes

KW - Gestational Diabetes

KW - hyperglycaemia in pregnancy

KW - pregnancy complications

KW - screening

KW - large for gestational age

KW - blood glucose

KW - Pregnancy

U2 - 10.1016/j.ogrm.2017.03.004

DO - 10.1016/j.ogrm.2017.03.004

M3 - Article

SN - 1879-3622

VL - 27

SP - 171

EP - 176

JO - Obstetrics, Gynaecology & Reproductive Medicine

JF - Obstetrics, Gynaecology & Reproductive Medicine

IS - 6

ER -